Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story stocks' without revenue, let alone profit. But the reality is that when a company ...

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling short, can easily find investors. But as Peter Lynch said in One Up On Wall ...

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. But as Peter Lynch said ...

Antares Pharma (AMEX: AIS) reported earnings on May 8. Here are the numbers you need to know. The 10-second takeaway For the quarter ended March 31 (Q1), Antares Pharma crushed expectations on ...

Antares Pharma (Nasdaq: ATRS) reported earnings on Aug. 8. Here are the numbers you need to know. The 10-second takeaway For the quarter ended June 30 (Q2), Antares Pharma missed estimates on revenues ...

For the quarter ended March 31 (Q1), Antares Pharma whiffed on revenues and met expectations on earnings per share. Compared to the prior-year quarter, revenue shrank significantly. GAAP earnings per ...

Antares Pharma (ATRS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2021. This widely-known consensus outlook ...

For the quarter ended March 31 (Q1), Antares Pharma crushed expectations on revenues and beat expectations on earnings per share. Compared to the prior-year quarter, revenue improved significantly and ...